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Background | The Center for Medicare and Medicaid 
Services (CMS) identified opioid abuse as a critical 
priority for 2019 and is expected to continue as a 
priority over the next five years.1 Opioid abuse is 
characterized as the “intentional, nontherapeutic use of 
a drug or substance for the purpose of achieving a 
psychological or physiological effect.” 2 Strong 
evidence shows that opioid abuse is causing a 
significant economic burden by directly impacting 
costs of care, utilization, and societal financial 
burden.3 Studies have attempted to identify risk factors 
that could predict opioid overdose, often for patients 
with specified morbidity or focused on specific high-
risk populations.4,5 A medical claims data study of 
over 42,000 Colorado patients taking chronic opioid 
therapy, found that mental health diagnoses, substance 
use disorders, long-acting and extended-release opioid 
formulations, and tobacco use were significant opioid 
overdose predictors.4  
 
However, there is very little research on hospital 
structural characteristics and their potential influence 
on opioid abuse. Most studies explore the impact of 
hospital structure on opioid related adverse events, for 
example, one study was identified that researched 
hospitals in 32 states participating in the Healthcare 
Cost and Utilization Project (HCUP). This study found 
that preventable opioid related adverse events were 
higher in urban teaching hospitals as well as private, 
not-for-profit hospitals.6  However, since the 
community and its health system are connected,7 there 
may be an influence of hospital structural 
characteristics and opioid abuse. This influence should 
be further examined due to the absence of outpatient 
factors in consideration. 
 
Florida is one of eight states that is labeled a high-
burden opioid abuse. Florida suffers from one of the 
highest concentrations of fentanyl-related overdoses 
and is considered an “epicenter” for opioid use.8,9  In 
Florida, synthetic opioids are responsible for the sharp 
increase in abuse, characterized by high overdose 
deaths. In 2018, the overdose death rate in Florida was 
15.8 per 100,000. This was higher than the national 
average of 14.6 per 100,000.10  In 2017, Fentanyl and 
Fentanyl analogs contributed to around 28,400 deaths, 
Background: With over two million people suffering from opioid abuse disorders, the Centers 
for Medicare and Medicaid Services has identified opioid abuse as a key priority. Florida is one 
of eight states labeled as a high-burden opioid abuse and is an “epicenter” for opioid use and 
misuse. Purpose: The purpose of this study was to discover potential predictors of opioid abuse 
in Florida by exploring specific healthcare delivery, geographic, and patient demographic 
factors. Methods: A retrospective longitudinal study design was used to examine four years 
(2014-2017) of Florida inpatient administrative discharge data across 173 hospitals of opioid 
abuse rate. Main measures included, opioid abuse counts (n=12,804) defined using both ICD-9-
CM and ICD-10-CM systems. Negative binomial regression was used to estimate the 
association between hospital factors, county factor, and opioid abuse hospital rates. Results: 
We found a statistically significant association between hospital opioid abuse count and 
hospital size, location, teaching status, patients’ average age, gender, and race. The estimated 
probability of opioid abuse for a patient if treated in a large hospital is 0.23 (about 23%), 
significantly higher than small (8%) and medium (17%) size hospitals. The estimated 
probability of opioid abuse for a patient if treated in a rural hospital is 0.12 (about 12%), while 
in an urban hospital is higher at 0.17 (about 17%). The risk ratio is 0.71, which means the risk 
decreased by two-thirds when treated in rural hospitals. We also found that hospitals with a 
younger patient population, a higher percent of males and a higher proportion of Caucasian 
patients, are at a higher risk for an increase in opioid abuse counts. Discussion: These findings 
provide policymakers with crucial insight into Florida’s opioid crisis and the identification of 
predictive factors that contribute to opioid abuse. 
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the sharpest increase in overdose deaths.10 While 
Florida’s opioid-related emergency department visit 
rates have drastically increased by 32.3% from 2009 
to 2014,11 prescription rates have decreased by as 
much as 80%.12 This decrease is possibly a result of 
Florida’s prescription drug monitoring programs and 
“pill mill” laws.9 However, despite the decrease, 
inpatient stays due to opioid utilization in Florida are 
far higher than the national average.13 Thus, this study 
explored the potential predictive relationship between 
patient characteristics, hospital structural 
characteristics and county characteristics and their 
predictive impact on opioid abuse.  
 
Methods | Data Sources The 2014-2017 Florida 
Inpatient Discharge (FID) data was obtained from the 
Agency for Health Care Administration’s Center for 
Health Information and Transparency and linked to the 
2017 American Hospital Association (AHA) annual 
survey using Medicare Provider Numbers. Also, we 
used the 2014-2017 US Census Bureau Current 
Population Survey (CPS) and linked it using county 
Federal Information Processing Standards (FIPS). The 
FID data contained over 13 million discharges for all 
hospitals in Florida and recorded information 
regarding the patients, diagnoses, procedures, costs 
and attending physicians. Specifically, the data 
recorded 30 diagnosis codes and procedure codes, 
making it a comprehensive dataset for diagnosis 
selection. The AHA annual survey collects 
information about all U.S. hospitals regarding 
organizational structure, financial well-being, 
workforce, and services. The CPS collects information 
on household adults 18 years of age or older and 
provides 1- and 5-year estimates of population 
characteristics.  
 
Variables and Measures Outcome variable. Our 
primary outcome variable was a hospital’s total 
number of opioid abuse related stays during our study 
period (2014 to 2017). Opioid abuse stays were 
identified using principle and secondary ICD-9-CM 
and ICD-10-CM codes presented in Table 1. The 
codes were extracted from prior research and the 
Healthcare Cost and Utilization Project (HCUP).14,15 
 





305.50  Opioid abuse, unspecified 
305.51  Opioid abuse, continuous 
305.52  Opioid abuse, episodic 
 F11.10 Opioid abuse, uncomplicated 
 F11.120 Opioid abuse with intoxication, uncomplicated 
 F11.121 Opioid abuse with intoxication delirium 
 F11.122 Opioid abuse with intoxication with perceptual disturbance 
 F11.129 Opioid abuse with intoxication, unspecified 
 F11.14 Opioid abuse with opioid-induced mood disorder 
 F11.150 Opioid abuse with opioid-induced psychotic disorder with delusions 
 F11.151 Opioid abuse with opioid-induced psychotic disorder with hallucinations 
 F11.159 Opioid abuse with opioid-induced psychotic disorder, unspecified 
 F11.181 Opioid abuse with opioid-induced sexual dysfunction 
 F11.182 Opioid abuse with opioid-induced sleep disorder 
 F11.188 Opioid abuse with other opioid-induced disorder 
 F11.19 Opioid abuse with unspecified opioid-induced disorder 
 
Demographics of Patient Population. We identified 
key factors that have previously been identified as 
critical to determining opioid use, which included 
patient age, gender, patient priority level, and 
ethnicity.16-18  Patient age was reported as a hospital’s 
median patient age for the study year. Gender was 
reported as the percent of female patients at the 
hospital. Insurance status was reported as the percent 
of patients with commercial health insurance. Patient 
priority level was reported as hospitals’ percent of 
non-elective admissions. Non-elective admissions 
included emergency, urgent, and trauma admissions. 
Lastly, we included patient ethnicity, and it was 
reported as hospitals’ percent of patients who identify 
as African Americans or Blacks and hospitals’ percent 
of patients who identify as Latino/Hispanic. 
 
Hospital Characteristics. We identified vital hospital 
factors that have previously been found to impact 
patient utilization and community health. Hospital 
ownership was reported as a categorical variable (not-
for-profit, for-profit, and government-owned). An 
indication of the health of the community and services 
available are indicative of hospital ownership status.19 
Hospital location was reported as a categorical 
variable (rural and urban) and indicates hospital 
2
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resources, and state or federal funding support as 
urban hospitals have been found to be better funded 
and more efficient than rural hospitals.20  Hospital size 
was reported as a categorical variable of the number of 
staffed hospital beds (small <100, medium<400, and 
large 400+) and is an indication of hospital quality and 
market power.21 Teaching status was reported as a 
categorical variable (major, minor, non-teaching) and 
is an indication of hospital safety and quality.22 
Finally, we estimated an average hospitals’ market 
competition using the Herfindahl-Hirschman Index 
(HHI). A hospital HHI is a ratio of the total inpatient 
days and county’s total inpatient days (all hospitals in 
the county). A HHI of 0 is an indication of a 
competitive market, while an HHI of 1 is an indication 
of a monopolistic market.23,24  
County Characteristics. At the county level, we 
examined community diversity and poverty for the 
study period. These two variables provide insight into 
the county’s health disparity and health.25 We used an 
inequality index score that examines the amount of 
diversity and population evenness within a county, 26 
which we estimated by calculating the sum of the log 
proportions of each of the six racial/ethnic groups 
present in the US. These groups are African 
Americans, American Indians or Alaskan 
Natives, Asians, Native Hawaiians or other Pacific 
Islanders, Latino/Hispanics, and non-Latino/Hispanic 
Whites. The closer the score to 1.79, the more diverse 
(i.e., even) the population.27 County poverty was 
reported as the percent of the population below the 
federal poverty. These characteristics are necessary to 
evaluate the potential relationship between 
demographic factors and opioid misuse and abuse.  
 
Approach We chose to analyze the counts for opioid 
abuse counts at the hospital level due to the extremely 
low incidence at the individual patient level (0.56% 
overall). A retrospective longitudinal study design was 
used to examine four years (2014-2017) of Florida 
inpatient medical discharge data across 173 unique 
hospitals (a total of 12,804 opioid abuse incidents). 
The opioid abuse counts were analyzed using a 
generalized linear mixed model with a negative 
binomial distribution and a log-link function. The 
model included the hospital characteristics (ownership 
type, location, size, teaching affiliation), patient 
demographics at hospital level (average age, percent 
of female patients, percent of African American 
patients, percent of Latino/Hispanic patients, and 
percent of cases admitted through emergency/urgent 
care/trauma) and county-level characteristics 
(diversity index, HHI index and poverty percent) as 
fixed covariates. A random intercept was added for 
each provider to account for the random variation. The 
year was also included as another fixed covariate to 
examine the trend over time. The model also 
accounted for the difference in hospital sizes by using 
an offset variable (log of the total number of patients 
for each year); therefore, a fair comparison on the 
negative binomial rate (the probability of having an 
opioid abuse case for an individual patient) can be 
made. Generalized Chi-Square over degrees of 
freedom and residual plots were used to assess the 
goodness of fit of the model. The Kenward, Roger 28 
method was used for the calculation of the 
denominator degrees of freedom.29 All analyses were 
performed using SAS software, version 9.4.30 In 
accordance with the policy of the University, the 
Institutional Review Board (IRB) categorized the 
research as exempt since the study analyzed secondary 
data that is publicly available. 
 
Results | Figure 1 shows the distribution of opioid 
abuse counts in Florida hospitals for each year from 
2014 to 2017. The general patterns are similar from 
year to year, with a gradual increase in the right tails, 
which indicates the number of hospitals with a 
relatively high number of opioid abuse counts has 
increased.  
Table 2 displays the descriptive statistics of the opioid 
abuse counts at the hospital level from 2014 to 2017 in 
Florida. The mean and median number of opioid abuse 
reports steadily increased from 2014 to 2017. In 
addition, more hospitals reported a higher number of 
opioid abuse events during 2014 to 2017. For example, 
2 hospitals reported more than 100 opioid abuse events 
in 2014 and 2015, compared with 7 hospitals in 2016 
and 2017. The standard deviations from table 2 also 
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Figure 1: Florida Hospital Opioid Abuse Counts Distribution by Year 
 
 
Table 2: Summary of Florida Hospital Opioid Abuse Counts by Year 
 2014 2015 2016 2017 
Hospital, N 170 168 170 168 
Opioid Abuse 
Mean 12.5 16.2 22.2 24.9 
STD 17.4 23.9 31.4 33.6 
Median 6.0 8.0 12.0 13.5 
Min 0 0 0 0 
Max 117 203 230 220 
Note: N: number of hospitals with records; STD: standard deviation 
 
Table 3 displays the parameter estimate results for all 
key variables in the model, except for the ownership 
type, which was not significant; all the other variables 
of hospital characteristics were statistically 
significant. All variables of patient demographics were 
statistically significant. The diversity index was the 
only variable that was statistically significant at the 
county level. Compared with 2014, the opioid abuse 
rate was significantly increased in 2016 and 2017 
(2015 was not statistically significantly different from 
in 2014). Furthermore, we may estimate the 
relationship between each of the variables with the risk 
(probability) of a patient encountering opioid abuse at 
a hospital. For example, hospitals with a younger 
patient mix, a higher percent of male patients, and a 
higher proportion of Caucasian patients more likely to 
report a higher incidence of opioid abuse. Patients 
treated in hospitals located in a county with a higher 
diversity index tend to have a higher risk of opioid 
abuse. The estimated coefficients also show the 
magnitude of impact for each variable. For example, 
the variable ‘Mean Age’ has a coefficient of -0.053, 
which means that for each one-year increase on 
average age in the patient population, the expected log 
of the negative binomial rate decreases by 0.05. On the 
other hand, the variable ‘Diversity Index’ has a 
coefficient of 1.01, which means that for each one-unit 
increase on the diversity index score, the expected log 
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Table 3: Negative Binomial Regression Parameter Estimates 
Variable Coefficient 




Hospital Characteristics  
 Ownership Status (Referent: Not-for-profit)  
For-profit -0.05 
Government -0.004 
 Location (Referent: Urban)  
Rural -0.37 
 Size (Referent: Small)  
Large 1.09** 
Medium 0.77** 
 Teaching Status (Referent: Non-Teaching)  
Major 0.15 
Minor 0.24** 
Patient Characteristics  
 Mean Age -0.05** 
 Percent Female -0.05** 
 Percent Emergency, Urgent and Trauma Admissions 0.02** 
 Percent African American -0.01* 
 Percent Latino/Hispanic -0.02** 
County Characteristics  
 Diversity Index 1.01** 
 Herfindahl-Hirschman Index 0.23 
 Percent Poverty 0.01 
Note: * significant at 0.05; ** significant at 0.01  
 
Table 4 displays the estimate of the opioid abuse rate 
(risk/probability of a patient being opioid abused) for 
all the categorical variables in the model. The risk 
ratios were calculated from the estimates. The risk 
ratio in this context is the risk of opioid abuse when a 
patient is treated in each condition versus the reference 
level. Using hospital location, for example, the 
estimated probability of opioid abuse for a patient if 
treated in a rural hospital is 0.12 (about 12%), while in 
an urban hospital is 0.17 (about 17%). The risk ratio is 
0.71, which means the risk of opioid abuse is 
decreased by 30% when a patient is treated in rural 
hospitals. No significant difference is discovered in 
the hospital ownership type, with the risk at 14%. For 
hospital size, the risks of a patient to be opioid abused 
is 22%, 17%, and 8% when treated in large, medium, 
and small hospitals, respectively. The risk ratios are 
2.96 (large vs. small) and 2.16 (medium vs. small), 
which indicates the risk is significantly higher at large 
or medium hospitals compared with small hospitals. 
There is no significant difference in the risk between 
major and minor teaching hospitals. However, the risk 
at both major and minor teaching hospitals is higher 
than the non-teaching hospitals. Lastly, the increasing 
trend of opioid abuse rates is observed starting from 
2016. The increase in the risk of opioid abuse over 
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Table 4: Negative Binomial Regression Opioid Abuse Rate Estimates 
Main Effect  LS Mean Lower CL Upper CL Risk Ratio 
Location     
Rural 0.12 0.07 0.19 0.71 
Urban 0.17 0.14 0.20  
Ownership status     
For-profit 0.14 0.1 0.18 0.95 
Government 0.14 0.10 0.21 0.95 
Not-for-profit 0.14 0.11 0.19  
Size     
Large 0.23 0.16 0.31 2.96 
Medium 0.17 0.12 0.22 2.16 
Small 0.08 0.05 0.11  
Teaching status     
Major 0.15 0.10 0.21 1.16 
Minor 0.16 0.12 0.21 1.27 
Non-Teaching 0.12 0.10 0.16  
Year     
2015 0.12 0.09 0.16 1.03 
2016 0.17 0.13 0.22 1.40 
2017 0.19 0.14 0.25 1.47 
2014 0.11 0.08 0.14  
Note: LS: least squares; CL: confident level 
 
 
Discussion | This study examined potential predictors 
of opioid abuse in Florida through specific healthcare 
delivery, geographic, and patient demographic factors. 
The results from this study suggest that hospitals in 
Florida are continuously reporting higher counts of 
opioid abuse over the years. Our binomial regression 
analysis indicated a statistically significant increase in 
opioid abuse in Florida. A probable explanation for 
these results is a decrease in the uninsured population 
and an increase in the awareness of opioid misuse 
leading to more accurate reporting.  
 
For example, the passing of the 2010 Patient 
Protection and Affordable Care Act (ACA) provided a 
reduction of financial barriers for the treatment of 
opioid use disorders.31 Changes under the ACA 
increased access to hospitals by removing the 
administrative barriers that impeded the timely 
payment for clinician reimbursement allowing 
hospitals to be more prone to addressing this issue 32. 
This change allowed for an increase in treatment 
access and utilization, which may explain the 
increased reporting. In addition, in 2015 the US began 
using the ICD-10-CM, which increased codes from 
14,000 to 68,000 codes, which may have contributed 
to more accurate documentation of patients with 
opioid abuse disorders and a 14.1% increase of 
inpatient stays with opioid-related diagnoses.14  
 
Furthermore, our study found a significant relationship 
between hospital size and volume increase of opioid 
abuse. Large and medium-sized hospitals were found 
to experience higher counts of patients with opioid 
abuse disorders compared to small-sized hospitals 
even when we adjust for other factors. This may be 
attributed to any number of factors, including the 
possibility of larger hospitals to have more resources 
compared to their small and medium counterparts. Our 
results showed that out of a total of 183 hospitals, 170 
reported they had encountered patients with opioid 
abuse disorder with 3% from the total sample that did 
not report. Perhaps larger hospitals have the resources 
to better identify patients with opioid abuse disorder.  
 
Our findings also indicated that the majority of Florida 
hospitals with a higher risk for opioid abuse are 
located in urban areas. A possible explanation for this 
finding would be that urban populations are more 
susceptible to abuse due to better access to 
prescription opioids. While one study 33 showed that 
residents living in rural counties are more likely to take 
opioids for pain relief compared to those living in 
urban areas, another study34 showed that individuals in 
urban areas are more likely to engage in misuse 
because of their higher exposure to other substances 
and access to care. A study by Sears, Edmonds, & 
Fulton-Kehoe35 found a higher prevalence of 
prescribing physicians and pharmacists in urban areas. 
Trends in studies show that abundant supplies of 
opioids are positively correlated to abuse in urban 
areas with individuals in urban counties having 
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increased access to pain management physicians and 
pharmacies.33,36,37  
 
Another study from Cerdá et al.38 supports this 
sentiment by finding a correlation between changes in 
pharmacy density and opioid abuse discharge rates in 
urban areas, particularly prescription-opioid poisoning 
rates. As prescription opioids are more readily 
available in urban settings, the risk of abuse in such 
areas increases consequently. Individuals in rural areas 
would have less access to treatment programs and 
would likely have to travel to urban areas in order to 
get access to treatment.39 Another study found that 
treatment services are more readily available to urban 
residents than their rural counterparts.40 In addition, 
one study found a correlation between concentrated 
homelessness in urban settings and higher risks of 
opioid abuse with homeless individuals having a 
disproportionately higher risk of opioid abuse 
disorders compared to individuals of lower-income 
households.41  
 
Regarding the characteristics of patients who are of 
higher risk, our study found that among the 2014-2017 
Florida patient population, those who were younger, 
male, and Caucasian were found to be more at risk of 
being identified with an opioid abuse disorder. This is 
an important finding because it supports other research 
that as a person ages, they have a decreased risk of 
opioid abuse.42,43 Furthermore, our findings support 
studies that males are more likely to abuse opioids 
compared to females.43,44 This is also consistent with 
literature related to risk factors for opioid abuse among 
veterans and younger adult males having a higher 
prevalence of opioid abuse disorder.44 This study uses 
data from multiple databases to provide valuable 
insight into our understanding of potential predictors 
for opioid abuse disorder. However, the data is 
focused on Florida hospitals and the patient population 
within Florida. Therefore, the results are not 
generalizable to other states.  
 
Policy Implications | Despite its limitations, this 
study provides important insight into Florida’s opioid 
crisis and the identification of predictive factors that 
contribute to opioid abuse. The results of our study 
indicate that there is a statistically significant 
association between opioid abuse rate and hospital 
size, location, and teaching status. These are important 
findings because it provides valuable insight for 
policymakers to direct limited resources in an effort to 
reduce the prevalence of opioid misuse and abuse. To 
more effectively utilize the limited resources 
associated to combat opioid abuse, our research 
indicates that policymakers should target policies at 
larger hospitals, in urban locations, and those 
designated as teaching hospitals. It is important for 
policymakers to understand these predictive patient 
characteristics because this type of demographic data 
is readily available. The understanding of patient 
characteristics and their association to opioid misuse 
and abuse can help policymakers more effectively and 
more efficiently target limited resources, like opioid 
cessation education programs, to specific populations.  
Finally, the findings presented in our study are 
especially important to providers and hospital 
administrators who are increasingly experiencing 
legislative interventions to reduce unnecessary and 
excessive opioid prescribing patterns. Therefore, it is 
important for hospital administrators and other 
providers to use this data to proactively identify 
solutions to improve population health by measurably 
reducing practices that contribute to the misuse and 
abuse of opioids.   
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